Statutory Ineligibility and the Mandated Transition Between Calculation Methods for the Massachusetts Research and Development Tax Credit

The designation of a taxpayer as “Not Eligible to Compute Under § 38M(a)” indicates that the entity lacks the requisite gross receipts in the third and fourth years preceding the credit year to establish a valid fixed-base ratio. Consequently, Massachusetts law mandates that such taxpayers calculate their research credit exclusively under the Alternative Simplified Method provided in Section 38M(b).1

Theoretical and Statutory Foundations of the Massachusetts Research Credit

The Massachusetts Research Credit, established under M.G.L. c. 63, § 38M, is a sophisticated tax incentive designed to stimulate high-technology investment and intellectual property development within the Commonwealth. While the credit historically mirrored the federal research credit under Internal Revenue Code (IRC) § 41, the Massachusetts version has evolved into a distinct regulatory regime with its own eligibility triggers, calculation constraints, and administrative interpretations.2 The legal architecture of the credit is primarily defined by the statute itself, but its practical application is governed by the Massachusetts Department of Revenue (DOR) through Technical Information Releases (TIRs), such as TIR 14-13 and TIR 25-3, and comprehensive regulations under 830 CMR 63.38M.1 and 830 CMR 63.38M.2.3 Understanding the specific phrase regarding ineligibility under subsection (a) requires a deep dive into the mechanical evolution of the state’s tax reform in 2014 and the resulting mandatory filing requirements for emerging businesses.

Historical Context and the 2014 Economic Growth Act

For decades, the Massachusetts research credit was limited to a single calculation method that relied heavily on complex historical data. This “Regular Method,” which today resides in Section 38M(a), required businesses to reconstruct their spending and revenue history back to a base period, a task that proved insurmountable for many startups and companies with fragmented records.6 Recognizing that the rigidity of the original credit was stifling the very innovation it sought to foster, the Massachusetts legislature enacted “An Act Promoting Economic Growth Across the Commonwealth” in 2014.4

Sections 54 and 123 of the 2014 Act fundamentally re-wrote Section 38M, effective for tax years beginning on or after January 1, 2015. These reforms accomplished several objectives: they introduced the Alternative Simplified Method (ASM), changed the definition of “base amount” to use a fixed-base ratio rather than a fixed-base percentage, and established a seven-year phase-in period for the ASM credit rate.4 The introduction of the ASM was a direct response to the “mathematical trap” that penalized companies with high revenue but fluctuating R&D expenditures, as well as those that lacked the historical data necessary to compute a traditional base.6

The Mechanics of Section 38M(a) and the Ineligibility Trigger

Section 38M(a) provides the “Regular Method” for calculating the research credit. This method is generally advantageous for mature corporations that have established long-term revenue streams and consistent research spending. The credit is equal to 10% of the excess of qualified research expenses (QREs) over a “base amount,” plus 15% of basic research payments.7 However, the eligibility for this method is contingent upon the taxpayer’s ability to satisfy a specific mathematical formula derived from historical performance.

Defining the Fixed-Base Ratio

The “base amount” under Section 38M(a) is determined by multiplying the taxpayer’s average annual gross receipts for the four taxable years preceding the credit year by a “fixed-base ratio”.4 The fixed-base ratio itself is calculated by taking the total of the taxpayer’s QREs for the third and fourth taxable years preceding the credit year and dividing that amount by the taxpayer’s total gross receipts for those same two taxable years.1

The statutory formula for the fixed-base ratio is:

$$Fixed\text{-}Base Ratio = \frac{QRE_{Year -3} + QRE_{Year -4}}{Gross Receipts_{Year -3} + Gross Receipts_{Year -4}}$$

This ratio is capped at 16% to prevent an excessively high base amount from neutralizing the credit.1 In determining this ratio, the Commissioner of Revenue has the authority to aggregate the activities of all corporations that are members of a controlled group, ensuring that companies cannot artificially manipulate the ratio by shifting receipts or expenses among subsidiaries.7

The Zero-Receipt Ineligibility Rule

The critical administrative threshold occurs when the denominator of the fixed-base ratio—the total gross receipts for the third and fourth preceding years—is zero. Because division by zero is mathematically undefined, the taxpayer cannot establish a base amount using the method prescribed in Section 38M(a). Consequently, official DOR guidance and the instructions for Schedule RC explicitly state that such a taxpayer is “not eligible to compute its credit using the method prescribed under MGL ch 63, § 38M(a)”.1

This is not a matter of taxpayer preference or an elective choice; it is a mandatory statutory redirection. Taxpayers who find themselves in this “not eligible” category must instead calculate their credit using the Alternative Simplified Method (ASM) under Section 38M(b).1 This rule most frequently impacts early-stage startups, pre-revenue biotechnology firms, and newly formed subsidiaries that are in the development phase and have not yet generated commercial sales.

The Alternative Simplified Method (ASM) Under Section 38M(b)

The Alternative Simplified Method was designed precisely to accommodate taxpayers who are either ineligible for the Regular Method or who find the Regular Method’s data requirements too burdensome.6 The ASM focuses on recent research spending trends rather than long-term revenue history. This methodology aligns Massachusetts more closely with the federal alternative simplified credit under IRC § 41(c)(5).4

Calculation of the ASM Credit

Under Section 38M(b), the credit is calculated as a percentage of the current year’s QREs that exceed 50% of the average QREs for the three taxable years preceding the credit year.1 Following a seven-year phase-in period, the credit rate for calendar years beginning on or after January 1, 2021, is set at 10%.4

The ASM formula is:

$$Credit_{ASM} = 10\% \times (QRE_{Current Year} – (50\% \times Average QRE_{Preceding 3 Years}))$$

For a taxpayer deemed “not eligible” for the Regular Method due to lack of historical revenue, the ASM provides a viable path to securing research incentives. If the taxpayer did not have any QREs in any one of the three years preceding the current taxable year, a secondary rule applies: the credit is equal to 5% of the total QREs for the current year.1 This “Startup Provision” ensures that even the newest ventures receive a benefit for their initial Massachusetts-based R&D investments, albeit at a lower percentage than firms that have established a spending baseline.4

Election and Continuity Requirements

While the choice between the Regular Method and the ASM is generally an annual election for eligible taxpayers, those mandated into the ASM due to the zero-receipt rule are functionally making a mandatory filing.1 For all other taxpayers, the election to use the ASM is made by checking the appropriate box on Schedule RC.1 Once an election is made, it is generally intended to be a long-term choice, and taxpayers are advised to consult with advisors before switching, although the statute technically allows for annual flexibility.2

Regulatory Guidance and Administrative Compliance

The Massachusetts Department of Revenue has issued extensive regulations to clarify the definitions and procedural requirements for both the Regular Method and the ASM. These regulations, primarily 830 CMR 63.38M.1 and 63.38M.2, provide the granular detail necessary for corporate tax compliance.

Defining Massachusetts Qualified Research Expenses

A foundational requirement for either method is that the expenses must be “Massachusetts Qualified Research Expenses.” To meet this definition, the expenses must satisfy a two-pronged test: they must qualify as research expenses under IRC § 41(b), and they must have been incurred for research activity conducted physically within the borders of Massachusetts.3

Specific types of qualifying expenses include:

• Wages: Salaries paid for qualified services performed in Massachusetts, including those paid to employees directly conducting research or those supervising and supporting research.2
• Supplies: Amounts paid for tangible property (excluding land and improvements) used or consumed in Massachusetts in the conduct of qualified research.3
• Computer Fees: Payments for the right to use computers located in Massachusetts, provided the research itself also takes place in Massachusetts.3
• Contract Research: 65% of the amounts paid to third parties for research activity conducted at a research facility located in Massachusetts.3

If services or property are used both inside and outside the state, the expenses must be prorated based on the ratio of the number of days the service provider or property was used in Massachusetts to the total number of days employed.14

The Election to Use Massachusetts Gross Receipts

A significant regulatory nuance involves the calculation of “gross receipts” for the base amount. A corporation may elect to compute its gross receipts using only those receipts attributable to Massachusetts sales, rather than total federal gross receipts.1 This election must be made on the original return for the first year the credit is claimed and is binding for three taxable years.1

This election can have a profound impact on eligibility for the Regular Method. A multi-state corporation might have substantial federal gross receipts but zero Massachusetts-sourced receipts. If such a corporation elects to use Massachusetts gross receipts, it would be deemed “not eligible” to compute under Section 38M(a) and would be forced into the ASM, despite its overall size.1

TIR 25-3 and the Extension to Financial Institutions

Recent litigation has expanded the universe of taxpayers who must navigate these eligibility rules. In the case of State Street Corporation v. Commissioner of Revenue, the Appellate Tax Board ruled that financial institutions taxed under M.G.L. c. 63, § 2 are “business corporations” for the purpose of claiming the Section 38M research credit.5 Previously, the DOR had restricted the credit to corporations taxed under Section 39.

TIR 25-3 formally adopted the Board’s decision, allowing financial institutions to claim the credit and, importantly, allowing them to file amended returns to elect the ASM for prior years.5 For these large institutions, the “not eligible” status for Section 38M(a) is unlikely to be a factor due to their significant historical revenue, but the procedural flexibility regarding ASM elections on amended returns represents a major shift in administrative policy.5

Practical Application: Comprehensive Case Study

To contextualize the “not eligible” status, consider the evolution of a hypothetical Massachusetts technology firm, “Nexus Robotics.”

Year 1 through Year 4: The Startup Phase

Nexus Robotics was formed in 2021. For its first four years, it focused exclusively on prototype development and software engineering.

• 2021-2023: The company incurred $2,000,000 in annual QREs but generated $0 in gross receipts.
• 2024: The company began its first pilot projects, generating $500,000 in gross receipts, while increasing QREs to $3,500,000.

Year 5: The Credit Year (2025 Filing)

In 2025, the company prepares its tax return for the 2024 credit year. It first analyzes its eligibility for the Regular Method under Section 38M(a).

• Step 1: Fixed-Base Ratio Calculation. The company looks at the third and fourth years preceding 2024 (which are 2021 and 2020). Since the company did not exist or had zero revenue in those years, the denominator for the fixed-base ratio is zero.1
• Step 2: Determining Eligibility. Because the aggregate gross receipts for the third and fourth preceding years are zero, Nexus Robotics is “Not Eligible to Compute Under § 38M(a)”.1
• Step 3: Calculating under ASM. Nexus Robotics must use Section 38M(b). It calculates its average QREs for the three preceding years (2021, 2022, 2023).

• 3rd Preceding Year (2021): $2,000,000
• 2nd Preceding Year (2022): $2,000,000
• 1st Preceding Year (2023): $2,000,000
• Average QRE: $2,000,000
• ASM Base (50% of Average): $1,000,000

• Step 4: Final Credit Amount.

• Current QRE (2024): $3,500,000
• Excess over Base: $2,500,000
• Credit (10%): $250,000.7

Year 5: Limitations and Carryover

The final step is applying the statutory limitations. Nexus Robotics has a total corporate excise liability of $100,000 in 2024.

• $25,000 Limitation: The credit can offset 100% of the first $25,000 in liability, plus 75% of the liability exceeding $25,000.2

• First $25,000 Offset: $25,000
• Remaining Liability ($75,000) Offset at 75%: $56,250
• Total Credit Used: $81,250

• Carryforward: The remaining credit ($250,000 – $81,250 = $168,750) is carried forward.13

• Portion disallowed by the 75% rule ($18,750) is carried forward indefinitely.1
• The remainder is carried forward for 15 years.1

Aggregation and Combined Reporting for Group Members

The determination of “not eligible” status is further complicated when a corporation is part of an aggregated group. Massachusetts requires groups under common control to compute a single credit for the entire group, which is then allocated among the members.3

Aggregated Computation Mechanics

An “aggregated group” includes two or more corporations that are members of the same controlled group as defined by IRC § 41(f)(5), regardless of whether all members do business in Massachusetts.3 In determining the group’s credit, all relevant expenses and receipts from intercompany transactions are disregarded.3

For the purpose of Section 38M(a) eligibility, the group’s combined gross receipts for the third and fourth preceding years are evaluated. If the aggregate gross receipts are zero, then no member of the group is eligible for the Regular Method.1 If the aggregate receipts are greater than zero, the group establishes a single fixed-base ratio and a single base amount, which is then used to calculate the group’s total credit.3

Allocation and Limitations for Group Members

Once the group credit is calculated, it is allocated to each member corporation subject to Massachusetts excise based on that member’s share of the total QREs.3 Each member then applies its share of the credit against its own excise liability, subject to the $25,000 and 75% limitations.3 Notably, the $25,000 threshold (which is not subject to the 75% limitation) is a single amount shared by the entire group, allocated in proportion to each member’s separately determined excise liability.2

Economic Significance and Policy Implications

The design of the Massachusetts Research Credit, particularly the mandatory shift to the ASM for revenue-less companies, reflects a strategic policy decision to protect and promote the state’s innovation clusters. By providing an “on-ramp” for startups that lack historical revenue, the Commonwealth maintains its competitive position against other high-tech hubs.

The Value of R&D to the Commonwealth

Data from the University of Massachusetts Donahue Institute and the Department of Revenue highlights the immense scale of R&D activity in the state. Massachusetts is a top-three state for NIH and NSF funding and typically leads the nation in per capita research investment.16 Every dollar invested in Massachusetts R&D supports nearly double that amount in total economic activity.16

The economic impact of large research entities is particularly striking. Mass General Brigham, the largest hospital-based research enterprise in the U.S., had a total economic impact of $53.4 billion from 2017 to 2021—an amount exceeding the entire annual state budget.17 The research credit serves as a critical financial pillar for these organizations, allowing them to sustain employment for over 80,000 people and drive innovations that lead to hundreds of new patents and businesses.17

Tax Expenditure Budgeting and Regional Competition

The “cost” of the research credit is tracked as a tax expenditure. For Fiscal Year 2025, the Commonwealth projected the cost of the research credit (Expenditure 2.604) to reach $1.16 billion, representing a steady increase from $792 million in FY2021.18 This investment is viewed as necessary to compete with regional neighbors like New York and Connecticut.

Massachusetts takes a unique approach to limitations. While Maine offers a 5% credit rate and New York generally caps credits at 6% of QREs, Massachusetts offers a high 10% rate combined with a very generous carryover policy.19 The ability to carry forward credits disallowed by the 75% rule indefinitely is a major differentiator that provides long-term value to capital-intensive sectors like life sciences and aerospace.2

Specialized Sector Provisions: Life Sciences and Defense

The Massachusetts research credit framework includes distinct pathways for the life sciences and defense sectors, which are the primary beneficiaries of the “not eligible” and ASM provisions.

The Life Sciences Tax Incentive Program

Certified life sciences companies have access to a separate credit under M.G.L. c. 63, § 38W.1 This program, managed by the Massachusetts Life Sciences Center (MLSC), allows companies to request a refund of up to 90% of their unused research credits.12 This is a crucial liquidity mechanism for biotechnology firms that are in the “not eligible” phase—conducting years of research without revenue.

However, a corporation cannot claim both the general § 38M credit and the § 38W credit for the same expenses.1 Furthermore, firms claiming the life sciences credit do not use Schedule RC, but instead report their authorized amount on Schedule CMS.1 For many startups, the choice between the § 38M ASM and the § 38W refundable credit depends on their current certification status with the MLSC and their immediate need for cash flow versus long-term carryforward assets.

Defense-Related Activity Bifurcation

Under Section 38M(i), a taxpayer may elect to calculate its research credit separately for defense-related activities.8 This election allows a company to isolate the QREs and gross receipts associated with government contracts for arms, ammunition, and, more recently, biologic products and medical supplies used to treat chemical or radiological threats.1

By separating these activities, a defense contractor can potentially bypass the “not eligible” trigger if their commercial side has revenue but their new defense research subsidiary does not. This bifurcation requires separate tracking of all expenses and receipts and provides a strategic layer for multi-sector engineering and technology firms.1

Compliance and Record-Keeping Obligations

Regardless of the calculation method used, the DOR mandates strict record-keeping to substantiate research credit claims. For companies forced into the ASM because they are “not eligible” for the Regular Method, documenting the absence of revenue is as important as documenting the presence of expenses.

Substantiation Requirements

Regulation 830 CMR 63.38M.2(16) outlines the accounting requirements for the credit.1 Taxpayers must maintain:

• Historical Financial Records: Tax returns and financial statements for the four preceding years to prove the gross receipts denominator.1
• Contemporary Research Documentation: Lab notebooks, project descriptions, and meeting minutes that satisfy the federal “four-part test” for qualified research (technological in nature, permitted purpose, elimination of uncertainty, and process of experimentation).2
• Payroll and Contract Data: Detailed breakdowns of wages paid for research services performed in Massachusetts and contracts for research conducted at Massachusetts-based facilities.3

Failure to maintain adequate records can lead to a full disallowance of the credit. During an audit, the DOR will scrutinize the “ineligibility” claim for Section 38M(a) to ensure the taxpayer did not bypass the receipts-based calculation to achieve a higher credit under the ASM.1

Conclusion: Strategic Perspectives on Ineligibility

The designation of being “Not Eligible to Compute Under § 38M(a)” is a foundational element of the Massachusetts R&D tax landscape. It serves as a gateway that directs emerging, high-growth, and pre-revenue companies toward the Alternative Simplified Method, ensuring they can still access vital tax incentives despite lacking the historical revenue required for traditional models. This statutory mechanism, supported by the 2014 reforms and recent administrative updates like TIR 25-3, reinforces Massachusetts’ position as a premier destination for global R&D investment.

By understanding the mathematical triggers of the fixed-base ratio and the mandatory nature of the ASM for revenue-less entities, businesses can more accurately forecast their tax liabilities and the long-term value of their R&D credits. As the Commonwealth’s innovation economy continues to expand into new sectors like offshore wind and digital finance, the nuance and flexibility of Section 38M will remain a cornerstone of state tax policy, driving both immediate job creation and the long-term development of transformative technologies.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/